Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Voluven on postoperative morbidity after gynaecological surgery
2006-004720-37Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Sep 2006
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Volulyte in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Incidence of nausea and vomiting. Started Sep 2006; status: completed.
02
Drugs
Volulyte
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on 2006-004720-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004720-37.